<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-01-01" modified="2017-12-20" version="228">
<accession>P06493</accession>
<accession>A8K7C4</accession>
<accession>C9J497</accession>
<accession>O60764</accession>
<name>CDK1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cyclin-dependent kinase 1</fullName>
<shortName>CDK1</shortName>
<ecNumber>2.7.11.22</ecNumber>
<ecNumber>2.7.11.23</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cell division control protein 2 homolog</fullName>
</alternativeName>
<alternativeName>
<fullName>Cell division protein kinase 1</fullName>
</alternativeName>
<alternativeName>
<fullName>p34 protein kinase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CDK1</name>
<name type="synonym">CDC2</name>
<name type="synonym">CDC28A</name>
<name type="synonym">CDKN1</name>
<name type="synonym">P34CDC2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="Nature" volume="327" first="31" last="35">
<title>Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2.</title>
<authorList>
<person name="Lee M.G."/>
<person name="Nurse P."/>
</authorList>
<dbReference type="PubMed" id="3553962"/>
<dbReference type="DOI" id="10.1038/327031a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Cancer Res." volume="58" first="1095" last="1098">
<title>T-loop deletion of CDC2 from breast cancer tissues eliminates binding to cyclin B1 and cyclin-dependent kinase inhibitor p21.</title>
<authorList>
<person name="Ohta T."/>
<person name="Okamoto K."/>
<person name="Isohashi F."/>
<person name="Shibata K."/>
<person name="Fukuda M."/>
<person name="Yamaguchi S."/>
<person name="Xiong Y."/>
</authorList>
<dbReference type="PubMed" id="9515786"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Mammary cancer</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="submission" date="2002-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1988" name="Cell" volume="54" first="17" last="26">
<title>Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement.</title>
<authorList>
<person name="Draetta G."/>
<person name="Beach D."/>
</authorList>
<dbReference type="PubMed" id="3289755"/>
<dbReference type="DOI" id="10.1016/0092-8674(88)90175-4"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>ASSOCIATION WITH P13</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1995" name="Science" volume="270" first="86" last="90">
<title>Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15.</title>
<authorList>
<person name="Mueller P.R."/>
<person name="Coleman T.R."/>
<person name="Kumagai A."/>
<person name="Dunphy W.G."/>
</authorList>
<dbReference type="PubMed" id="7569953"/>
<dbReference type="DOI" id="10.1126/science.270.5233.86"/>
</citation>
<scope>PHOSPHORYLATION AT THR-14 AND TYR-15 BY PKMYT1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="Blood" volume="90" first="1047" last="1054">
<title>The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2.</title>
<authorList>
<person name="Kupfer G.M."/>
<person name="Yamashita T."/>
<person name="Naf D."/>
<person name="Suliman A."/>
<person name="Asano S."/>
<person name="D'Andrea A.D."/>
</authorList>
<dbReference type="PubMed" id="9242535"/>
</citation>
<scope>INTERACTION WITH FANCC</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="Eur. J. Biochem." volume="243" first="527" last="536">
<title>Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.</title>
<authorList>
<person name="Meijer L."/>
<person name="Borgne A."/>
<person name="Mulner O."/>
<person name="Chong J.P.J."/>
<person name="Blow J.J."/>
<person name="Inagaki N."/>
<person name="Inagaki M."/>
<person name="Delcros J.-G."/>
<person name="Moulinoux J.-P."/>
</authorList>
<dbReference type="PubMed" id="9030781"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1997.t01-2-00527.x"/>
</citation>
<scope>ENZYME REGULATION BY ROSCOVITINE AND OLOMOUCINE</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="30597" last="30604">
<title>RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis.</title>
<authorList>
<person name="Rosse C."/>
<person name="L'Hoste S."/>
<person name="Offner N."/>
<person name="Picard A."/>
<person name="Camonis J."/>
</authorList>
<dbReference type="PubMed" id="12775724"/>
<dbReference type="DOI" id="10.1074/jbc.M302191200"/>
</citation>
<scope>INTERACTION WITH RALBP1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="32592" last="32602">
<title>Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region.</title>
<authorList>
<person name="Hsu J.-M."/>
<person name="Lee Y.-C.G."/>
<person name="Yu C.-T.R."/>
<person name="Huang C.-Y.F."/>
</authorList>
<dbReference type="PubMed" id="15145941"/>
<dbReference type="DOI" id="10.1074/jbc.M404950200"/>
</citation>
<scope>INTERACTION WITH DLGAP5</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="7118" last="7128">
<title>Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation.</title>
<authorList>
<person name="Qiao M."/>
<person name="Shapiro P."/>
<person name="Fosbrink M."/>
<person name="Rus H."/>
<person name="Kumar R."/>
<person name="Passaniti A."/>
</authorList>
<dbReference type="PubMed" id="16407259"/>
<dbReference type="DOI" id="10.1074/jbc.M508162200"/>
</citation>
<scope>FUNCTION AS RUNX2 KINASE</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Mol. Biol. Cell" volume="17" first="1041" last="1050">
<title>Microtubule regulation in mitosis: tubulin phosphorylation by the cyclin-dependent kinase Cdk1.</title>
<authorList>
<person name="Fourest-Lieuvin A."/>
<person name="Peris L."/>
<person name="Gache V."/>
<person name="Garcia-Saez I."/>
<person name="Juillan-Binard C."/>
<person name="Lantez V."/>
<person name="Job D."/>
</authorList>
<dbReference type="PubMed" id="16371510"/>
<dbReference type="DOI" id="10.1091/mbc.E05-07-0621"/>
</citation>
<scope>FUNCTION AS BETA-TUBULINS KINASE</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="11393" last="11401">
<title>Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells.</title>
<authorList>
<person name="Westbrook L."/>
<person name="Manuvakhova M."/>
<person name="Kern F.G."/>
<person name="Estes N.R. II"/>
<person name="Ramanathan H.N."/>
<person name="Thottassery J.V."/>
</authorList>
<dbReference type="PubMed" id="18056467"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-4173"/>
</citation>
<scope>INDUCTION BY CKS1B</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Cytokine" volume="37" first="155" last="162">
<title>TGFbeta regulates the expression and activities of G2 checkpoint kinases in human myeloid leukemia cells.</title>
<authorList>
<person name="Hu X."/>
<person name="Cui D."/>
<person name="Moscinski L.C."/>
<person name="Zhang X."/>
<person name="Maccachero V."/>
<person name="Zuckerman K.S."/>
</authorList>
<dbReference type="PubMed" id="17459720"/>
<dbReference type="DOI" id="10.1016/j.cyto.2007.03.009"/>
</citation>
<scope>FUNCTION AS RB1 KINASE</scope>
<scope>ENZYME REGULATION BY TGFB1</scope>
<scope>REPRESSION BY TGFB1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Neurochem. Res." volume="32" first="187" last="195">
<title>Microtubule deacetylases, SirT2 and HDAC6, in the nervous system.</title>
<authorList>
<person name="Southwood C.M."/>
<person name="Peppi M."/>
<person name="Dryden S."/>
<person name="Tainsky M.A."/>
<person name="Gow A."/>
</authorList>
<dbReference type="PubMed" id="16933150"/>
<dbReference type="DOI" id="10.1007/s11064-006-9127-6"/>
</citation>
<scope>FUNCTION AS SIRT2 KINASE</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Mol. Biol. Cell" volume="19" first="3426" last="3441">
<title>Rapid cycling and precocious termination of G1 phase in cells expressing CDK1AF.</title>
<authorList>
<person name="Pomerening J.R."/>
<person name="Ubersax J.A."/>
<person name="Ferrell J.E. Jr."/>
</authorList>
<dbReference type="PubMed" id="18480403"/>
<dbReference type="DOI" id="10.1091/mbc.E08-02-0172"/>
</citation>
<scope>FUNCTION DURING THE M PHASE</scope>
<scope>MUTAGENESIS OF 14-THR-TYR-15</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-19; SER-39; TYR-77 AND THR-222</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14 AND TYR-15</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Science" volume="319" first="1665" last="1668">
<title>Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons.</title>
<authorList>
<person name="Yuan Z."/>
<person name="Becker E.B.E."/>
<person name="Merlo P."/>
<person name="Yamada T."/>
<person name="DiBacco S."/>
<person name="Konishi Y."/>
<person name="Schaefer E.M."/>
<person name="Bonni A."/>
</authorList>
<dbReference type="PubMed" id="18356527"/>
<dbReference type="DOI" id="10.1126/science.1152337"/>
</citation>
<scope>FUNCTION AS FOXO1 KINASE</scope>
<scope>INTERACTION WITH FOXO1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="J. Cell Sci." volume="122" first="2240" last="2251">
<title>Sequential phosphorylation of Nedd1 by Cdk1 and Plk1 is required for targeting of the gammaTuRC to the centrosome.</title>
<authorList>
<person name="Zhang X."/>
<person name="Chen Q."/>
<person name="Feng J."/>
<person name="Hou J."/>
<person name="Yang F."/>
<person name="Liu J."/>
<person name="Jiang Q."/>
<person name="Zhang C."/>
</authorList>
<dbReference type="PubMed" id="19509060"/>
<dbReference type="DOI" id="10.1242/jcs.042747"/>
</citation>
<scope>FUNCTION AS NEDD1 KINASE</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-19; SER-39; SER-178; THR-222 AND SER-248</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; TYR-15 AND THR-161</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="393" first="872" last="876">
<title>Mitotic phosphorylation of Aki1 at Ser208 by cyclin B1-Cdk1 complex.</title>
<authorList>
<person name="Nakamura A."/>
<person name="Naito M."/>
<person name="Arai H."/>
<person name="Fujita N."/>
</authorList>
<dbReference type="PubMed" id="20171170"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.02.103"/>
</citation>
<scope>FUNCTION AS CC2D1A KINASE</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="EMBO Rep." volume="11" first="393" last="399">
<title>New Cdc2 Tyr 4 phosphorylation by dsRNA-activated protein kinase triggers Cdc2 polyubiquitination and G2 arrest under genotoxic stresses.</title>
<authorList>
<person name="Yoon C.-H."/>
<person name="Miah M.A."/>
<person name="Kim K.P."/>
<person name="Bae Y.-S."/>
</authorList>
<dbReference type="PubMed" id="20395957"/>
<dbReference type="DOI" id="10.1038/embor.2010.45"/>
</citation>
<scope>FUNCTION IN G2 ARREST UPON DNA DAMAGE</scope>
<scope>PHOSPHORYLATION AT TYR-4 BY PKR/EIF2AK2</scope>
<scope>POLYUBIQUITINATION</scope>
<scope>MUTAGENESIS OF TYR-4</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="1879" last="1887">
<title>The protein kinase Cdelta catalytic fragment is critical for maintenance of the G2/M DNA damage checkpoint.</title>
<authorList>
<person name="LaGory E.L."/>
<person name="Sitailo L.A."/>
<person name="Denning M.F."/>
</authorList>
<dbReference type="PubMed" id="19917613"/>
<dbReference type="DOI" id="10.1074/jbc.M109.055392"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-15</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="16978" last="16990">
<title>Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition.</title>
<authorList>
<person name="Timofeev O."/>
<person name="Cizmecioglu O."/>
<person name="Settele F."/>
<person name="Kempf T."/>
<person name="Hoffmann I."/>
</authorList>
<dbReference type="PubMed" id="20360007"/>
<dbReference type="DOI" id="10.1074/jbc.M109.096552"/>
</citation>
<scope>FUNCTION IN G2-M TRANSITION</scope>
<scope>DEPHOSPHORYLATION AT THR-14 AND TYR-15 BY CDC25</scope>
<scope>PHOSPHORYLATION AT THR-161 BY CDK7/CAK</scope>
<scope>INTERACTION WITH B-CYCLIN</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="640" last="656">
<title>Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis.</title>
<authorList>
<person name="Terrano D.T."/>
<person name="Upreti M."/>
<person name="Chambers T.C."/>
</authorList>
<dbReference type="PubMed" id="19917720"/>
<dbReference type="DOI" id="10.1128/MCB.00882-09"/>
</citation>
<scope>FUNCTION AS BCL-XL/BCL2L1 KINASE</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="5726" last="5740">
<title>Cdk1/cyclin B1 controls Fas-mediated apoptosis by regulating caspase-8 activity.</title>
<authorList>
<person name="Matthess Y."/>
<person name="Raab M."/>
<person name="Sanhaji M."/>
<person name="Lavrik I.N."/>
<person name="Strebhardt K."/>
</authorList>
<dbReference type="PubMed" id="20937773"/>
<dbReference type="DOI" id="10.1128/MCB.00731-10"/>
</citation>
<scope>FUNCTION AS CASP8 KINASE</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="1108" last="1114">
<title>Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2.</title>
<authorList>
<person name="Chen S."/>
<person name="Bohrer L.R."/>
<person name="Rai A.N."/>
<person name="Pan Y."/>
<person name="Gan L."/>
<person name="Zhou X."/>
<person name="Bagchi A."/>
<person name="Simon J.A."/>
<person name="Huang H."/>
</authorList>
<dbReference type="PubMed" id="20935635"/>
<dbReference type="DOI" id="10.1038/ncb2116"/>
</citation>
<scope>FUNCTION AS EZH2 KINASE</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="2129" last="2139">
<title>Cep63 recruits Cdk1 to the centrosome: implications for regulation of mitotic entry, centrosome amplification, and genome maintenance.</title>
<authorList>
<person name="Loffler H."/>
<person name="Fechter A."/>
<person name="Matuszewska M."/>
<person name="Saffrich R."/>
<person name="Mistrik M."/>
<person name="Marhold J."/>
<person name="Hornung C."/>
<person name="Westermann F."/>
<person name="Bartek J."/>
<person name="Kramer A."/>
</authorList>
<dbReference type="PubMed" id="21406398"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-2684"/>
</citation>
<scope>INTERACTION WITH CEP63</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="EMBO J." volume="30" first="130" last="144">
<title>CAMP (C13orf8, ZNF828) is a novel regulator of kinetochore-microtubule attachment.</title>
<authorList>
<person name="Itoh G."/>
<person name="Kanno S."/>
<person name="Uchida K.S."/>
<person name="Chiba S."/>
<person name="Sugino S."/>
<person name="Watanabe K."/>
<person name="Mizuno K."/>
<person name="Yasui A."/>
<person name="Hirota T."/>
<person name="Tanaka K."/>
</authorList>
<dbReference type="PubMed" id="21063390"/>
<dbReference type="DOI" id="10.1038/emboj.2010.276"/>
</citation>
<scope>FUNCTION AS CHAMP1 KINASE</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2005" name="Trends Biochem. Sci." volume="30" first="630" last="641">
<title>Mammalian cyclin-dependent kinases.</title>
<authorList>
<person name="Malumbres M."/>
<person name="Barbacid M."/>
</authorList>
<dbReference type="PubMed" id="16236519"/>
<dbReference type="DOI" id="10.1016/j.tibs.2005.09.005"/>
</citation>
<scope>REVIEW ON SUBSTRATES</scope>
<scope>GENE FAMILY</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2009" name="J. Cell Biol." volume="185" first="193" last="202">
<title>The decision to enter mitosis: feedback and redundancy in the mitotic entry network.</title>
<authorList>
<person name="Lindqvist A."/>
<person name="Rodriguez-Bravo V."/>
<person name="Medema R.H."/>
</authorList>
<dbReference type="PubMed" id="19364923"/>
<dbReference type="DOI" id="10.1083/jcb.200812045"/>
</citation>
<scope>REVIEW ON SUBCELLULAR TRANSLOCATION</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2009" name="Nat. Rev. Cancer" volume="9" first="153" last="166">
<title>Cell cycle, CDKs and cancer: a changing paradigm.</title>
<authorList>
<person name="Malumbres M."/>
<person name="Barbacid M."/>
</authorList>
<dbReference type="PubMed" id="19238148"/>
<dbReference type="DOI" id="10.1038/nrc2602"/>
</citation>
<scope>REVIEW ON CELL CYCLE CONTROL AND INHIBITORS</scope>
<scope>GENE FAMILY</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2011" name="Cell Prolif." volume="44" first="205" last="211">
<title>Cdc2: a monopotent or pluripotent CDK?</title>
<authorList>
<person name="Hu X."/>
<person name="Moscinski L.C."/>
</authorList>
<dbReference type="PubMed" id="21535261"/>
<dbReference type="DOI" id="10.1111/j.1365-2184.2011.00753.x"/>
</citation>
<scope>REVIEW ON CELL CYCLE CONTROL</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2011" name="Curr. Med. Chem." volume="18" first="2025" last="2043">
<title>Cyclin dependent kinase 1 inhibitors: a review of recent progress.</title>
<authorList>
<person name="Wang Q."/>
<person name="Su L."/>
<person name="Liu N."/>
<person name="Zhang L."/>
<person name="Xu W."/>
<person name="Fang H."/>
</authorList>
<dbReference type="PubMed" id="21517772"/>
<dbReference type="DOI" id="10.2174/092986711795590110"/>
</citation>
<scope>REVIEW ON CELL CYCLE CONTROL AND INHIBITORS</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2011" name="F1000 Biol. Rep." volume="3" first="10" last="10">
<title>Checkpoint recovery in cells: how a molecular understanding can help in the fight against cancer.</title>
<authorList>
<person name="Medema R.H."/>
<person name="Macurek L."/>
</authorList>
<dbReference type="PubMed" id="21655336"/>
<dbReference type="DOI" id="10.3410/B3-10"/>
</citation>
<scope>REVIEW ON CELL CYCLE CONTROL</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2011" name="Nat. Med." volume="17" first="589" last="595">
<title>EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.</title>
<authorList>
<person name="Lupberger J."/>
<person name="Zeisel M.B."/>
<person name="Xiao F."/>
<person name="Thumann C."/>
<person name="Fofana I."/>
<person name="Zona L."/>
<person name="Davis C."/>
<person name="Mee C.J."/>
<person name="Turek M."/>
<person name="Gorke S."/>
<person name="Royer C."/>
<person name="Fischer B."/>
<person name="Zahid M.N."/>
<person name="Lavillette D."/>
<person name="Fresquet J."/>
<person name="Cosset F.L."/>
<person name="Rothenberg S.M."/>
<person name="Pietschmann T."/>
<person name="Patel A.H."/>
<person name="Pessaux P."/>
<person name="Doffoel M."/>
<person name="Raffelsberger W."/>
<person name="Poch O."/>
<person name="McKeating J.A."/>
<person name="Brino L."/>
<person name="Baumert T.F."/>
</authorList>
<dbReference type="PubMed" id="21516087"/>
<dbReference type="DOI" id="10.1038/nm.2341"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39; THR-141 AND THR-161</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2015" name="Biochem. Biophys. Res. Commun." volume="468" first="642" last="646">
<title>Phosphorylation of the centrosomal protein, Cep169, by Cdk1 promotes its dissociation from centrosomes in mitosis.</title>
<authorList>
<person name="Mori Y."/>
<person name="Inoue Y."/>
<person name="Taniyama Y."/>
<person name="Tanaka S."/>
<person name="Terada Y."/>
</authorList>
<dbReference type="PubMed" id="26549230"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2015.11.004"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2015" name="Dev. Cell" volume="32" first="68" last="81">
<title>Dynamic phosphorylation of CENP-A at Ser68 orchestrates its cell-cycle-dependent deposition at centromeres.</title>
<authorList>
<person name="Yu Z."/>
<person name="Zhou X."/>
<person name="Wang W."/>
<person name="Deng W."/>
<person name="Fang J."/>
<person name="Hu H."/>
<person name="Wang Z."/>
<person name="Li S."/>
<person name="Cui L."/>
<person name="Shen J."/>
<person name="Zhai L."/>
<person name="Peng S."/>
<person name="Wong J."/>
<person name="Dong S."/>
<person name="Yuan Z."/>
<person name="Ou G."/>
<person name="Zhang X."/>
<person name="Xu P."/>
<person name="Lou J."/>
<person name="Yang N."/>
<person name="Chen P."/>
<person name="Xu R.M."/>
<person name="Li G."/>
</authorList>
<dbReference type="PubMed" id="25556658"/>
<dbReference type="DOI" id="10.1016/j.devcel.2014.11.030"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CENPA</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-9; LYS-20 AND LYS-139</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<comment type="function">
<text evidence="19 20 21 22 24 25 26 28 29 30 31 32 33 34 37 38">Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition, and regulates G1 progress and G1-S transition via association with multiple interphase cyclins. Required in higher cells for entry into S-phase and mitosis. Phosphorylates PARVA/actopaxin, APC, AMPH, APC, BARD1, Bcl-xL/BCL2L1, BRCA2, CALD1, CASP8, CDC7, CDC20, CDC25A, CDC25C, CC2D1A, CENPA, CSNK2 proteins/CKII, FZR1/CDH1, CDK7, CEBPB, CHAMP1, DMD/dystrophin, EEF1 proteins/EF-1, EZH2, KIF11/EG5, EGFR, FANCG, FOS, GFAP, GOLGA2/GM130, GRASP1, UBE2A/hHR6A, HIST1H1 proteins/histone H1, HMGA1, HIVEP3/KRC, LMNA, LMNB, LMNC, LBR, LATS1, MAP1B, MAP4, MARCKS, MCM2, MCM4, MKLP1, MYB, NEFH, NFIC, NPC/nuclear pore complex, PITPNM1/NIR2, NPM1, NCL, NUCKS1, NPM1/numatrin, ORC1, PRKAR2A, EEF1E1/p18, EIF3F/p47, p53/TP53, NONO/p54NRB, PAPOLA, PLEC/plectin, RB1, UL40/R2, RAB4A, RAP1GAP, RCC1, RPS6KB1/S6K1, KHDRBS1/SAM68, ESPL1, SKI, BIRC5/survivin, STIP1, TEX14, beta-tubulins, MAPT/TAU, NEDD1, VIM/vimentin, TK1, FOXO1, RUNX1/AML1, SIRT2 and RUNX2. CDK1/CDC2-cyclin-B controls pronuclear union in interphase fertilized eggs. Essential for early stages of embryonic development. During G2 and early mitosis, CDC25A/B/C-mediated dephosphorylation activates CDK1/cyclin complexes which phosphorylate several substrates that trigger at least centrosome separation, Golgi dynamics, nuclear envelope breakdown and chromosome condensation. Once chromosomes are condensed and aligned at the metaphase plate, CDK1 activity is switched off by WEE1- and PKMYT1-mediated phosphorylation to allow sister chromatid separation, chromosome decondensation, reformation of the nuclear envelope and cytokinesis. Inactivated by PKR/EIF2AK2- and WEE1-mediated phosphorylation upon DNA damage to stop cell cycle and genome replication at the G2 checkpoint thus facilitating DNA repair. Reactivated after successful DNA repair through WIP1-dependent signaling leading to CDC25A/B/C-mediated dephosphorylation and restoring cell cycle progression. In proliferating cells, CDK1-mediated FOXO1 phosphorylation at the G2-M phase represses FOXO1 interaction with 14-3-3 proteins and thereby promotes FOXO1 nuclear accumulation and transcription factor activity, leading to cell death of postmitotic neurons. The phosphorylation of beta-tubulins regulates microtubule dynamics during mitosis. NEDD1 phosphorylation promotes PLK1-mediated NEDD1 phosphorylation and subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. In addition, CC2D1A phosphorylation regulates CC2D1A spindle pole localization and association with SCC1/RAD21 and centriole cohesion during mitosis. The phosphorylation of Bcl-xL/BCL2L1 after prolongated G2 arrest upon DNA damage triggers apoptosis. In contrast, CASP8 phosphorylation during mitosis prevents its activation by proteolysis and subsequent apoptosis. This phosphorylation occurs in cancer cell lines, as well as in primary breast tissues and lymphocytes. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. CALD1 phosphorylation promotes Schwann cell migration during peripheral nerve regeneration. CDK1-cyclin-B complex phosphorylates NCKAP5L and mediates its dissociation from centrosomes during mitosis (PubMed:26549230).</text>
</comment>
<comment type="function">
<text evidence="36">(Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + [DNA-directed RNA polymerase] = ADP + [DNA-directed RNA polymerase] phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="22 41">Phosphorylation at Thr-14 or Tyr-15 inactivates the enzyme, while phosphorylation at Thr-161 activates it. Activated through a multistep process; binding to cyclin-B is required for relocation of cyclin-kinase complexes to the nucleus, activated by CAK/CDK7-mediated phosphorylation on Thr-161, and CDC25-mediated dephosphorylation of inhibitory phosphorylation on Thr-14 and Tyr-15. Inhibited by flavopiridol and derivatives, pyrimidine derivatives, pyridine derivatives, purine derivatives, staurosporine, paullones, oxoindoles, indazole analogs, indolin-2-ones, pyrazolo[3,4-b]pyridines, imidazo[1,2-a]pyridine (AZ703), thiazolinone analogs(RO-3306), thiazol urea, macrocyclic quinoxalin-2-one, pyrrolo[2,3-a]carbazole, pyrazolo[1,5-a]-1,3,5-triazine, pyrazolo[1,5-a]pyrimidine (Dinaciclib, SCH 727965), 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine (roscovitine), olomoucine, AG-024322, AT-7519, P276-00, R547/Ro-4584820 and SNS-032/BMS-387032. Repressed by the CDK inhibitors CDKN1A/p21 and CDKN1B/p27 during the G1 phase and by CDKN1A/p21 at the G1-S checkpoint upon DNA damage. Transient activation by rapid and transient dephosphorylation at Tyr-15 triggered by TGFB1.</text>
</comment>
<comment type="subunit">
<text evidence="17 18 24 30 35 37 42">Forms a stable but non-covalent complex with a regulatory subunit and with a cyclin. Interacts with cyclins-B (CCNB1, CCNB2 and CCNB3) to form a serine/threonine kinase holoenzyme complex also known as maturation promoting factor (MPF). The cyclin subunit imparts substrate specificity to the complex. Can also form CDK1-cylin-D and CDK1-cyclin-E complexes that phosphorylate RB1 in vitro. Binds to RB1 and other transcription factors such as FOXO1 and RUNX2. Promotes G2-M transition when in complex with a cyclin-B. Interacts with DLGAP5. Binds to the CDK inhibitors CDKN1A/p21 and CDKN1B/p27. Isoform 2 is unable to complex with cyclin-B1 and also fails to bind to CDKN1A/p21. Interacts with catalytically active CCNB1 and RALBP1 during mitosis to form an endocytotic complex during interphase. Associates with cyclins-A and B1 during S-phase in regenerating hepatocytes. Interacts with FANCC. Interacts with CEP63; this interaction recruits CDK1 to centrosomes. Interacts with CENPA (PubMed:25556658).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-617698">
<id>P03070</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-518823">
<id>O15392</id>
<label>BIRC5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-495332">
<id>P14635</id>
<label>CCNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>17</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-974439">
<id>P30307</id>
<label>CDC25C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-374862">
<id>Q99741</id>
<label>CDC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-375077">
<id>P38936</id>
<label>CDKN1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-456371">
<id>P61024</id>
<label>CKS1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-15621191">
<id>O75618-1</id>
<label>DEDD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-640775">
<id>P19525</id>
<label>EIF2AK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-1108782">
<id>Q12778</id>
<label>FOXO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-444209">
<id>O95835</id>
<label>LATS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-495308">
<id>Q99640</id>
<label>PKMYT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-444308"/>
<interactant intactId="EBI-3390054">
<id>P0CG48</id>
<label>UBC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Mitochondrion</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>cytoskeleton</location>
<location>microtubule organizing center</location>
<location>centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>cytoskeleton</location>
<location>spindle</location>
</subcellularLocation>
<text>Cytoplasmic during the interphase. Colocalizes with SIRT2 on centrosome during prophase and on splindle fibers during metaphase of the mitotic cell cycle. Reversibly translocated from cytoplasm to nucleus when phosphorylated before G2-M transition when associated with cyclin-B1. Accumulates in mitochondria in G2-arrested cells upon DNA-damage.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P06493-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P06493-2</id>
<name>2</name>
<name>CDC2deltaT</name>
<sequence type="described" ref="VSP_021375"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Isoform 2 is found in breast cancer tissues.</text>
</comment>
<comment type="induction">
<text evidence="22 23">Follows a cyclic expression; during interphase, accumulates gradually following G1, S to reach a critical threshold at the end of G2, which promotes self-activation and triggers onset of mitosis. Induced transiently by TGFB1 at an early phase of TGFB1-mediated apoptosis, but later repressed. Triggered by CKS1B during mitotic entry in breast cancer cells. Down-regulated under genotoxic stresses triggered by PKR/EIF2AK2-mediated phosphorylation.</text>
</comment>
<comment type="PTM">
<text evidence="27 30 31 39 40">Phosphorylation at Thr-161 by CAK/CDK7 activates kinase activity. Phosphorylation at Thr-14 and Tyr-15 by PKMYT1 prevents nuclear translocation. Phosphorylation at Tyr-15 by WEE1 and WEE2 inhibits the protein kinase activity and acts as a negative regulator of entry into mitosis (G2 to M transition). Phosphorylation by PKMYT1 and WEE1 takes place during mitosis to keep CDK1-cyclin-B complexes inactive until the end of G2. By the end of G2, PKMYT1 and WEE1 are inactivated, but CDC25A and CDC25B are activated. Dephosphorylation by active CDC25A and CDC25B at Thr-14 and Tyr-15, leads to CDK1 activation at the G2-M transition. Phosphorylation at Tyr-15 by WEE2 during oogenesis is required to maintain meiotic arrest in oocytes during the germinal vesicle (GV) stage, a long period of quiescence at dictyate prophase I, leading to prevent meiotic reentry. Phosphorylation by WEE2 is also required for metaphase II exit during egg activation to ensure exit from meiosis in oocytes and promote pronuclear formation. Phosphorylated at Tyr-4 by PKR/EIF2AK2 upon genotoxic stress. This phosphorylation triggers CDK1 polyubiquitination and subsequent proteolysis, thus leading to G2 arrest. In response to UV irradiation, phosphorylation at Tyr-15 by PRKCD activates the G2/M DNA damage checkpoint.</text>
</comment>
<comment type="PTM">
<text evidence="31">Polyubiquitinated upon genotoxic stress.</text>
</comment>
<comment type="miscellaneous">
<text evidence="45">As a key regulator of the cell cycle, CDK1 is a potent therapeutic target for inhibitors in cancer treatment.</text>
</comment>
<comment type="similarity">
<text evidence="44">Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.</text>
</comment>
<comment type="sequence caution" evidence="44">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="EAW54204" version="1"/>
</conflict>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/cdc2/"/>
</comment>
<dbReference type="EC" id="2.7.11.22"/>
<dbReference type="EC" id="2.7.11.23"/>
<dbReference type="EMBL" id="X05360">
<property type="protein sequence ID" value="CAA28963.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y00272">
<property type="protein sequence ID" value="CAA68376.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D88357">
<property type="protein sequence ID" value="BAA26001.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291939">
<property type="protein sequence ID" value="BAF84628.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007004">
<property type="protein sequence ID" value="AAP35650.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF512554">
<property type="protein sequence ID" value="AAM34793.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC022390">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471083">
<property type="protein sequence ID" value="EAW54204.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014563">
<property type="protein sequence ID" value="AAH14563.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44408.1">
<molecule id="P06493-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7260.1">
<molecule id="P06493-2"/>
</dbReference>
<dbReference type="PIR" id="A29539">
<property type="entry name" value="A29539"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307847.1">
<molecule id="P06493-1"/>
<property type="nucleotide sequence ID" value="NM_001320918.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001777.1">
<molecule id="P06493-1"/>
<property type="nucleotide sequence ID" value="NM_001786.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_203698.1">
<molecule id="P06493-2"/>
<property type="nucleotide sequence ID" value="NM_033379.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005270360.1">
<molecule id="P06493-1"/>
<property type="nucleotide sequence ID" value="XM_005270303.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.732435"/>
<dbReference type="PDB" id="1LC9">
<property type="method" value="Model"/>
<property type="chains" value="A=1-297"/>
</dbReference>
<dbReference type="PDB" id="4Y72">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-297"/>
</dbReference>
<dbReference type="PDB" id="4YC3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1-297"/>
</dbReference>
<dbReference type="PDB" id="4YC6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/C/E/G=1-297"/>
</dbReference>
<dbReference type="PDB" id="5HQ0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-297"/>
</dbReference>
<dbReference type="PDB" id="5LQF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.06"/>
<property type="chains" value="A/D=1-297"/>
</dbReference>
<dbReference type="PDBsum" id="1LC9"/>
<dbReference type="PDBsum" id="4Y72"/>
<dbReference type="PDBsum" id="4YC3"/>
<dbReference type="PDBsum" id="4YC6"/>
<dbReference type="PDBsum" id="5HQ0"/>
<dbReference type="PDBsum" id="5LQF"/>
<dbReference type="ProteinModelPortal" id="P06493"/>
<dbReference type="SMR" id="P06493"/>
<dbReference type="BioGrid" id="107420">
<property type="interactions" value="219"/>
</dbReference>
<dbReference type="CORUM" id="P06493"/>
<dbReference type="DIP" id="DIP-35N"/>
<dbReference type="ELM" id="P06493"/>
<dbReference type="IntAct" id="P06493">
<property type="interactions" value="100"/>
</dbReference>
<dbReference type="MINT" id="MINT-5000894"/>
<dbReference type="STRING" id="9606.ENSP00000378699"/>
<dbReference type="BindingDB" id="P06493"/>
<dbReference type="ChEMBL" id="CHEMBL308"/>
<dbReference type="DrugBank" id="DB04014">
<property type="generic name" value="Alsterpaullone"/>
</dbReference>
<dbReference type="DrugBank" id="DB05037">
<property type="generic name" value="AT7519"/>
</dbReference>
<dbReference type="DrugBank" id="DB03496">
<property type="generic name" value="Flavopiridol"/>
</dbReference>
<dbReference type="DrugBank" id="DB02950">
<property type="generic name" value="Hymenialdisine"/>
</dbReference>
<dbReference type="DrugBank" id="DB02052">
<property type="generic name" value="Indirubin-3'-Monoxime"/>
</dbReference>
<dbReference type="DrugBank" id="DB02116">
<property type="generic name" value="Olomoucine"/>
</dbReference>
<dbReference type="DrugBank" id="DB03428">
<property type="generic name" value="SU9516"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1961"/>
<dbReference type="TCDB" id="1.I.1.1.3">
<property type="family name" value="the eukaryotic nuclear pore complex (e-npc) family"/>
</dbReference>
<dbReference type="iPTMnet" id="P06493"/>
<dbReference type="PhosphoSitePlus" id="P06493"/>
<dbReference type="SwissPalm" id="P06493"/>
<dbReference type="BioMuta" id="CDK1"/>
<dbReference type="DMDM" id="334302921"/>
<dbReference type="SWISS-2DPAGE" id="P06493"/>
<dbReference type="EPD" id="P06493"/>
<dbReference type="MaxQB" id="P06493"/>
<dbReference type="PaxDb" id="P06493"/>
<dbReference type="PeptideAtlas" id="P06493"/>
<dbReference type="PRIDE" id="P06493"/>
<dbReference type="DNASU" id="983"/>
<dbReference type="Ensembl" id="ENST00000316629">
<molecule id="P06493-2"/>
<property type="protein sequence ID" value="ENSP00000325970"/>
<property type="gene ID" value="ENSG00000170312"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000373809">
<molecule id="P06493-2"/>
<property type="protein sequence ID" value="ENSP00000362915"/>
<property type="gene ID" value="ENSG00000170312"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000395284">
<molecule id="P06493-1"/>
<property type="protein sequence ID" value="ENSP00000378699"/>
<property type="gene ID" value="ENSG00000170312"/>
</dbReference>
<dbReference type="GeneID" id="983"/>
<dbReference type="KEGG" id="hsa:983"/>
<dbReference type="UCSC" id="uc001jld.3">
<molecule id="P06493-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="983"/>
<dbReference type="DisGeNET" id="983"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000170312.15"/>
<dbReference type="GeneCards" id="CDK1"/>
<dbReference type="HGNC" id="HGNC:1722">
<property type="gene designation" value="CDK1"/>
</dbReference>
<dbReference type="HPA" id="CAB003799"/>
<dbReference type="HPA" id="HPA003387"/>
<dbReference type="MIM" id="116940">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P06493"/>
<dbReference type="OpenTargets" id="ENSG00000170312"/>
<dbReference type="PharmGKB" id="PA99"/>
<dbReference type="eggNOG" id="KOG0594">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XPP3">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00900000140881"/>
<dbReference type="HOVERGEN" id="HBG014652"/>
<dbReference type="InParanoid" id="P06493"/>
<dbReference type="KO" id="K02087"/>
<dbReference type="OMA" id="EMMLVYD"/>
<dbReference type="PhylomeDB" id="P06493"/>
<dbReference type="TreeFam" id="TF101021"/>
<dbReference type="BRENDA" id="2.7.11.22">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-110056">
<property type="pathway name" value="MAPK3 (ERK1) activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-113507">
<property type="pathway name" value="E2F-enabled inhibition of pre-replication complex formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1362300">
<property type="pathway name" value="Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-162658">
<property type="pathway name" value="Golgi Cisternae Pericentriolar Stack Reorganization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-170145">
<property type="pathway name" value="Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-174048">
<property type="pathway name" value="APC/C:Cdc20 mediated degradation of Cyclin B"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-174184">
<property type="pathway name" value="Cdc20:Phospho-APC/C mediated degradation of Cyclin A"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176408">
<property type="pathway name" value="Regulation of APC/C activators between G1/S and early anaphase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176412">
<property type="pathway name" value="Phosphorylation of the APC/C"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176417">
<property type="pathway name" value="Phosphorylation of Emi1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2299718">
<property type="pathway name" value="Condensation of Prophase Chromosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2465910">
<property type="pathway name" value="MASTL Facilitates Mitotic Progression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2500257">
<property type="pathway name" value="Resolution of Sister Chromatid Cohesion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2514853">
<property type="pathway name" value="Condensation of Prometaphase Chromosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2565942">
<property type="pathway name" value="Regulation of PLK1 Activity at G2/M Transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2980767">
<property type="pathway name" value="Activation of NIMA Kinases NEK9, NEK6, NEK7"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3301854">
<property type="pathway name" value="Nuclear Pore Complex (NPC) Disassembly"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380259">
<property type="pathway name" value="Loss of Nlp from mitotic centrosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380270">
<property type="pathway name" value="Recruitment of mitotic centrosome proteins and complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380284">
<property type="pathway name" value="Loss of proteins required for interphase microtubule organization from the centrosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380320">
<property type="pathway name" value="Recruitment of NuMA to mitotic centrosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4419969">
<property type="pathway name" value="Depolymerisation of the Nuclear Lamina"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-539107">
<property type="pathway name" value="Activation of E2F1 target genes at G1/S"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5620912">
<property type="pathway name" value="Anchoring of the basal body to the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5687128">
<property type="pathway name" value="MAPK6/MAPK4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689896">
<property type="pathway name" value="Ovarian tumor domain proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804114">
<property type="pathway name" value="TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804757">
<property type="pathway name" value="Regulation of TP53 Degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-68875">
<property type="pathway name" value="Mitotic Prophase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69273">
<property type="pathway name" value="Cyclin A/B1/B2 associated events during G2/M transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69478">
<property type="pathway name" value="G2/M DNA replication checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75035">
<property type="pathway name" value="Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8852276">
<property type="pathway name" value="The role of GTSE1 in G2/M progression after G2 checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8854518">
<property type="pathway name" value="AURKA Activation by TPX2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8878166">
<property type="pathway name" value="Transcriptional regulation by RUNX2"/>
</dbReference>
<dbReference type="SignaLink" id="P06493"/>
<dbReference type="SIGNOR" id="P06493"/>
<dbReference type="ChiTaRS" id="CDK1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Cdk1"/>
<dbReference type="GeneWiki" id="Cyclin-dependent_kinase_1"/>
<dbReference type="GenomeRNAi" id="983"/>
<dbReference type="PRO" id="PR:P06493"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000170312"/>
<dbReference type="CleanEx" id="HS_CDC2"/>
<dbReference type="ExpressionAtlas" id="P06493">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P06493">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097125">
<property type="term" value="C:cyclin B1-CDK1 complex"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0000307">
<property type="term" value="C:cyclin-dependent protein kinase holoenzyme complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030496">
<property type="term" value="C:midbody"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005759">
<property type="term" value="C:mitochondrial matrix"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072686">
<property type="term" value="C:mitotic spindle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000784">
<property type="term" value="C:nuclear chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005876">
<property type="term" value="C:spindle microtubule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030332">
<property type="term" value="F:cyclin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0097472">
<property type="term" value="F:cyclin-dependent protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004693">
<property type="term" value="F:cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035173">
<property type="term" value="F:histone kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030544">
<property type="term" value="F:Hsp70 protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008353">
<property type="term" value="F:RNA polymerase II carboxy-terminal domain kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031145">
<property type="term" value="P:anaphase-promoting complex-dependent catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031100">
<property type="term" value="P:animal organ regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007569">
<property type="term" value="P:cell aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007098">
<property type="term" value="P:centrosome cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030261">
<property type="term" value="P:chromosome condensation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097711">
<property type="term" value="P:ciliary basal body-plasma membrane docking"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006977">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030855">
<property type="term" value="P:epithelial cell differentiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0090166">
<property type="term" value="P:Golgi disassembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000226">
<property type="term" value="P:microtubule cytoskeleton organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007095">
<property type="term" value="P:mitotic G2 DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007077">
<property type="term" value="P:mitotic nuclear envelope disassembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051436">
<property type="term" value="P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060045">
<property type="term" value="P:positive regulation of cardiac muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045740">
<property type="term" value="P:positive regulation of DNA replication"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010971">
<property type="term" value="P:positive regulation of G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1905448">
<property type="term" value="P:positive regulation of mitochondrial ATP synthesis coupled electron transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0033160">
<property type="term" value="P:positive regulation of protein import into nucleus, translocation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900182">
<property type="term" value="P:positive regulation of protein localization to nucleus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051437">
<property type="term" value="P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007344">
<property type="term" value="P:pronuclear fusion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006461">
<property type="term" value="P:protein complex assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034501">
<property type="term" value="P:protein localization to kinetochore"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0042787">
<property type="term" value="P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045995">
<property type="term" value="P:regulation of embryonic development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010389">
<property type="term" value="P:regulation of G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010468">
<property type="term" value="P:regulation of gene expression"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051445">
<property type="term" value="P:regulation of meiotic cell cycle"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0014038">
<property type="term" value="P:regulation of Schwann cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051439">
<property type="term" value="P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0014823">
<property type="term" value="P:response to activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014075">
<property type="term" value="P:response to amine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048678">
<property type="term" value="P:response to axon injury"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046686">
<property type="term" value="P:response to cadmium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046688">
<property type="term" value="P:response to copper ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045471">
<property type="term" value="P:response to ethanol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014070">
<property type="term" value="P:response to organic cyclic compound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009636">
<property type="term" value="P:response to toxic substance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0055015">
<property type="term" value="P:ventricular cardiac muscle cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Cyclin-dependent kinase 1" id="PRO_0000085724">
<location>
<begin position="1"/>
<end position="297"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="15">
<location>
<begin position="4"/>
<end position="287"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="15">
<location>
<begin position="10"/>
<end position="18"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="15 16">
<location>
<position position="128"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="15">
<location>
<position position="33"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="6 11">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PKR" evidence="31">
<location>
<position position="4"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="7">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="14">
<location>
<position position="9"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKMYT1" evidence="4 8 40">
<location>
<position position="14"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PKMYT1, WEE1, WEE2 and PKC/PRKCD" evidence="4 8 27 40">
<location>
<position position="15"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="5 6">
<location>
<position position="19"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 12">
<location>
<position position="39"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="5">
<location>
<position position="77"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12">
<location>
<position position="141"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CAK" evidence="8 9 10 12 30">
<location>
<position position="161"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="178"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 6">
<location>
<position position="222"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine" evidence="14">
<location>
<position position="245"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="248"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="13">
<location>
<position position="6"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="13">
<location>
<position position="9"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13">
<location>
<position position="20"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13">
<location>
<position position="139"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_021375" evidence="43">
<location>
<begin position="107"/>
<end position="163"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive polyubiquitination." evidence="31">
<original>Y</original>
<variation>D</variation>
<variation>E</variation>
<location>
<position position="4"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abnormal cell cycle exhibiting only M-phase without completing either karyokinesis or cytokinesis." evidence="25">
<original>TY</original>
<variation>AF</variation>
<location>
<begin position="14"/>
<end position="15"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1"/>
<end position="3"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="4"/>
<end position="12"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="17"/>
<end position="23"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="24"/>
<end position="26"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="29"/>
<end position="34"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="40"/>
<end position="42"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="46"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="66"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="75"/>
<end position="81"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="84"/>
<end position="86"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="87"/>
<end position="92"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="102"/>
<end position="120"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="121"/>
<end position="123"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="131"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="134"/>
<end position="136"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="149"/>
<end position="152"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="155"/>
<end position="157"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="161"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="166"/>
<end position="169"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="172"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="184"/>
<end position="199"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="209"/>
<end position="220"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="225"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="231"/>
<end position="233"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="249"/>
<end position="251"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="258"/>
<end position="267"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="272"/>
<end position="274"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="278"/>
<end position="281"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="285"/>
<end position="288"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="292"/>
<end position="295"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4YC3"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4YC6"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5LQF"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P11440"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12775724"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15145941"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16371510"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16407259"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16933150"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17459720"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18056467"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18356527"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18480403"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19509060"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19917613"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19917720"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20171170"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20360007"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20395957"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20935635"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20937773"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21063390"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21406398"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21516087"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25556658"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26549230"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3289755"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7569953"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9030781"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9242535"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9515786"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000305"/>
<evidence key="45" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21517772"/>
</source>
</evidence>
<sequence length="297" mass="34095" checksum="942D79448EFE490A" modified="2011-05-31" version="3">
MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRH
PNIVSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQILQGIVFCH
SRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSAR
YSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNT
FPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDNQIKKM
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>